EchoNous Vein receives FDA approval


EchoNous Vein (EchoNous), an ultrasound-based tool designed specifically for nurses to improve peripheral IV catheter placements, has received US Food and Drug Administration (FDA) approval.

A company release explains that EchoNous Vein provides immediate, clear images at depths from 1–5cm for quickly visualising superficial and deeper veins with just two-button controls. EchoNous Vein will integrate with the company’s existing intelligent medical tool, Uscan, to form the EchoNous platform.

One of the most commonly performed minimally-invasive procedures, peripheral IVs can be challenging due to chronic illness, chemotherapy, obesity and drug abuse; first-attempt IV catheter insertion fails in up to 26% of adults and 54% of children.

“Time is critical, especially when patients need an infusion or antibiotic treatment, and finding the right vein can be challenging. We designed the EchoNous Vein to provide nurses with rapid, clear images of veins to directly improve patient care, satisfaction and HCAHPS scores,” says Kevin Goodwin, CEO of EchoNous. “We wanted to create an easy-to-use tool that would help to reduce failed sticks, as with each failure comes a much higher risk of vessel trauma or infections which can lead to longer stays in hospital and higher medical costs.”

Early feedback from healthcare providers has shown the EchoNous Vein’s unique frequency profile and optimised gain and depth presets have the potential to provide significant advancements in evaluating veins of paediatric patients—a traditionally challenging patient population for IV insertion.

“EchoNous Vein’s simple on-screen controls allows clinicians using ultrasound to clearly identify veins in the centre of the display, helping to not just locate veins, but to evaluate their health and quality prior to peripheral IV placement,” says Nancy Moureau, CEO of PICC Excellence. “As clinicians we know that IV insertion selecting a healthy vein for catheter placement can help to reduce the chance of post insertional complications. To have a tool specifically designed to easily select veins and guide catheter placement is extremely valuable as we’re always looking to improve the patient experience.”

In addition to launching the new vascular access tool, the company also announces its plan to converge its Signostics brand and AI-driven Uscan bladder scanner product under the single EchoNous brand.


Please enter your comment!
Please enter your name here